Kailera Therapeutics Stock Price, News & Analysis
Why is KLRA Stock Up Today?
Company Description
Kailera Therapeutics (Nasdaq: KLRA) is a publicly traded biotechnology company in the Healthcare sector.
This page provides a comprehensive overview of KLRA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Kailera Therapeutics (KLRA) stock last traded at $26.00, up 7.08% from the previous close.
Latest News
Kailera Therapeutics has 1 recent news article, with the latest published 3 days ago. Key topics include IPO, offering. View all KLRA news →
SEC Filings
Financial Highlights
Upcoming Events
Offering expected close
Kailera Therapeutics has 1 upcoming scheduled event. The next event, "Offering expected close", is scheduled for April 20, 2026 (today). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the KLRA stock price.
Short Interest History
Days to Cover History
KLRA Company Profile & Sector Positioning
Kailera Therapeutics (KLRA) operates in the Biotechnology industry within the broader Healthcare sector.